Filing Details

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 INTERPACE BIOSICENCES, INC. (Name of Issuer) Common stock (Title of Class of Securities) 46062X303 (CUSIP Number) Ziyad Binsalamah 2806-1850 Old Main Street Houston, Texas, 77030, USA (Name, Address of Person Authorized to Receive Notices and Communications) 8/18/2020 (Date of Event which Requires Filing of this Statement) CUSIP No. 46062X303 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ziyad Binsalamah 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 SOURCE OF FUNDS (See Instructions) PF 5 DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ] 6 CITIZENSHIP OR PLACE OF ORGANIZATION Saudi Arabia NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 12 THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% 14 TYPE OF REPORTING PERSON (See Instructions) IN Item 1. Security and Issuer (a) Name of Issuer Interpace Biosciences, Inc. (b) Address of Issuer's Principal Executive Offices Morris Corporate Center 1, Building C 300 Interpace Parkway, Parsippany, NJ 07054 Item 2. Identity and Background (a) This statement on Schedule 13D/A is filed by Ziyad Binsalamah; an individual legal resident of the state of Texas (b) Address 2806-1850 Old Main Street, Houston, TX, 77030 (c) The Reporting Person is an individual investor (d) The reporting person has not, during the last five years, been convicted in a criminal proceeding (e) The reporting person has not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws (f) The reporting person is a citizen of Saudi Arabia Item 3. Source or Amount of Funds or Other Consideration A total amount of approximately $1,500,000.00 was paid to acquire the Shares reported as beneficially owned by the Reporting Person before selling them. The funds used to purchase these securities personal funds. All Shares were purchased and sold in the open market Item 4. Purpose of Transaction The Reporting Person sold all his Shares after the company reported a delay in filing form 10-Q due to some billing and compliance issues. Item 5. Interest in Securities of the Issuer (a) The aggregate percentage of shares reported sold by the Reporting Person was based on 4,036,595 Shares outstanding, which was the total number of Shares outstanding as reported in the 10-Q report on June 25, 2020 As of August 18, 2020, Ziyad Binsalamah beneficially owns 0 shares or 0% of the outstanding Shares. All Shares were sold by the Reporting Person. The Reporting Person does not own any Senior notes. (b) The Reporting Person had sole power to vote and dispose of the 307350 shares held by him individually. (c) The following Shares were purchased in the open market during the prior 60 days (based on settlement date): Purchaser DATE Number of Shares AVERAGE PRICE Ziyad Binsalamah 08/07/2020 2350 $6.45 Ziyad Binsalamah 07/27/2020 2200 $6.23 Ziyad Binsalamah 07/24/2020 2800 $6.23 Ziyad Binsalamah 07/23/2020 29000 $6.15 Ziyad Binsalamah 07/22/2020 30488 $6.2 Ziyad Binsalamah 07/21/2020 88811 $6.1 Ziyad Binsalamah 07/20/2020 52243 $5.5 Ziyad Binsalamah 07/17/2020 99458 $5.35

The following Shares were sold in the open market during the prior 60 days (based on settlement date): Seller DATE Number of shares AVERAGE PRICE Ziyad Binsalamah 08/18/2020 307350 $3.6 (d) No person other than the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares (e) Not applicable Item 6. Contracts, Arrangements, Understandings or relationships with Respect to Securities of the Issue There are no contracts, arrangements, understandings, or relationships between the Reporting Person and any other person with respect to any securities of the Issuer. Item 7. Material to Be Filed as Exhibits. None Item 8. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and were not held/sold for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and were not held/sold in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 8/20/2020 Dated /s/ Signature Ziyad Binsalamah, MD Name/Title